SCHEMBL4290854

SCHEMBL4290854

CN1CCN(c2ccc(C(=O)Nc3n[nH]c4c3CN(S(=O)(=O)c3cc(F)cc(F)c3)C4(C)C)c([N+](=O)[O-])c2)CC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 4/20 0.60
NTRK1 P04629 9/20 0.53
NTRK3 Q16288 6/20 0.53
NTRK2 Q16620 5/20 0.53
CCNA2 P20248 5/20 0.44
CDK2 P24941 5/20 0.44
CCNA1 P78396 5/20 0.44
PRKCB P05771 1/20 0.43
ALK Q9UM73 3/20 0.42
INSR P06213 2/20 0.42
PLK4 O00444 1/20 0.41
DAPK3 O43293 1/20 0.41
PRKCG P05129 1/20 0.41
ROS1 P08922 1/20 0.41
FER P16591 1/20 0.41
LTK P29376 1/20 0.41
WEE1 P30291 1/20 0.41
FRK P42685 1/20 0.41
MAPK8 P45983 1/20 0.41
MST1R Q04912 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4283518 0.92 NTRK1 (0.54) IGF1RNTRK1NTRK3NTRK2CCNA2
SCHEMBL4283380 0.90 IGF1R (0.64) IGF1RNTRK1NTRK3NTRK2CCNA2
SCHEMBL1370698 0.88 IGF1R (0.62) IGF1RNTRK1NTRK3NTRK2CCNA2
SCHEMBL4280821 0.88 IGF1R (0.62) IGF1RNTRK1NTRK3NTRK2CCNA2
SCHEMBL4282762 0.88 IGF1R (0.64) IGF1RNTRK1NTRK3NTRK2CCNA2
SCHEMBL12640221 0.86 IGF1R (0.62) IGF1RNTRK1NTRK3NTRK2CCNA2
SCHEMBL1373476 0.86 IGF1R (0.60) IGF1RNTRK1NTRK3NTRK2CCNA2
SCHEMBL4292286 0.86 IGF1R (0.73) IGF1RNTRK1NTRK3NTRK2CCNA2
SCHEMBL2021362 0.86 IGF1R (0.61) IGF1RNTRK1NTRK3NTRK2CCNA2
SCHEMBL1372958 0.86 IGF1R (0.61) IGF1RNTRK1NTRK3NTRK2CCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1999131-B1 BICYCLO-PYRAZOLES ACTIVE AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES SRL (IT) 2013-10-23 EP claimed
US-20090136513-A1 BICYCLO-PYRAZOLES ACTIVE AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L (IT) 2009-05-28 US claimed
US-9012487-B2 Bicyclo-pyrazoles active as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2015-04-21 US disclosed
US-9012487-B2 Bicyclo-pyrazoles active as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2015-04-21 US disclosed
US-9012487-B2 Bicyclo-pyrazoles active as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2015-04-21 US disclosed
EP-1999131-B1 BICYCLO-PYRAZOLES ACTIVE AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES SRL (IT) 2013-10-23 EP disclosed
US-20090136513-A1 BICYCLO-PYRAZOLES ACTIVE AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L (IT) 2009-05-28 US disclosed
US-20090136513-A1 BICYCLO-PYRAZOLES ACTIVE AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L (IT) 2009-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090136513-A1 BICYCLO-PYRAZOLES ACTIVE AS KINASE INHIBITORS MAP3K19, CDK2, MAP3K1 IGF1R 530/4885NTRK1 1106/4885NTRK3 892/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.